← All companies

CGEN

Compugen Ltd.

CGEN Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.38

+0.04 +1.71%

Key statistics

from XBRL data in SEC filings

Market cap

$225M

Revenue (TTM)

$72.8M

Net income (TTM)

$35.3M

EPS (TTM)

$0.38

P/E ratio

6.3

Dividend yield

—

Free cash flow

$31.3M

Cash

$90.6M

Total assets

$157M

Gross margin

87.3%

52-week range

$1.30 – $3.24

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Aug 3, 2026 6-K Aug 3, 2026 6-K ZK2635352 May 18, 2026 20-F Mar 2, 2026 6-K Mar 2, 2026 6-K Feb 12, 2026 6-K Dec 17, 2025 6-K Nov 10, 2025 6-K Oct 14, 2025 6-K Sep 17, 2025 6-K Aug 6, 2025 6-K Aug 6, 2025 6-K Jul 21, 2025 6-K May 19, 2025 6-K May 13, 2025 20-F Mar 4, 2025 6-K Mar 4, 2025 6-K Jan 8, 2025 6-K Nov 27, 2024 6-K Nov 12, 2024 6-K Nov 5, 2024 6-K Sep 13, 2024 6-K Aug 6, 2024 6-K Aug 5, 2024 6-K Jul 29, 2024 6-K May 30, 2024 6-K May 20, 2024 6-K May 15, 2024 20-F Mar 5, 2024 6-K Mar 5, 2024 6-K Feb 15, 2024 6-K Jan 8, 2024 6-K Dec 19, 2023 6-K Nov 7, 2023 6-K Nov 6, 2023 6-K Nov 3, 2023 6-K Sep 21, 2023 20-F/A Aug 23, 2023 6-K Aug 7, 2023 6-K Aug 7, 2023